Huawei readies for FTC complaint against InterDigital

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Huawei readies for FTC complaint against InterDigital

Chinese telecoms firm Huawei is set to complain to the US antitrust watchdog the FTC about InterDigital’s patent practices

Yesterday the US International Trade Commission (ITC) announced that it would investigate a complaint lodged by US non-practising entity InterDigital against telecoms companies Huawei, Samsung, Nokia and ZTE. In doing so, it rejected a request from Samsung and Huawei to delay proceedings while the US courts considered the dispute.

In its January 2 complaint, InterDigital accused the companies of infringing its patent rights in a series of smartphone and computer devices with wireless technologies and asked the ITC to stop the products being imported into the country.

InterDigital’s action is part of a long-running dispute with telecoms companies in the US and Europe.

Now Huawei’s chief legal officer, Song Liuping, has told Managing IP that the company plans to complain to the Federal Trade Commission about InterDigital’s licensing practices. But he declined to reveal when it would make its complaint.

Song compared the use of competition rules in China with those overseas.“There are many IP antitrust cases in the EU and the US to restrict the misuse of monopoly power. There are similar legal stipulations in China but far fewer cases,” he said.

In May last year, Huawei filed a complaint against InterDigital with the European Commission, alleging that the company had been trying to leverage its declared 3G standard essential patents to force Huawei to conclude a discriminatory, unfair and exploitative licence in breach of FRAND licensing practices.

InterDigital is being advised by Latham & Watkins in the US. Covington & Burling is acting for Huawei.

more from across site and SHARED ros bottom lb

More from across our site

Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Practitioners have welcomed extended funding of the specialist police unit until 2029, while the UKIPO says it is exploring increased scale
Abion says integration with Baylos marks an important step in the company’s international expansion plans
Via Licensing Alliance continues its China push as another smartphone manufacturer joins patent pool as licensee
Law firm mergers have the potential to reshape IP teams, and partners who were at the coalface of previous tie-ups say early coordination and flexibility can make the difference
Women are entering the IP profession, but still too few are being trusted with the clients, cases, and credit that may open the path to leadership
In other news, Australia’s IP office has announced expanded search options, and an EPO report shed light on slow progress relating to women inventors in Europe
Managing IP speaks with up-and-coming women lawyers at five law firms about fighting imposter syndrome, maintaining work-life balance and why real representation matters
Gift this article